Shares of Pfizer (NYSE:PFE) have bullishly opened above the pivot of $24.94 today and have reached the first resistance level of $25.16. Should the shares continue to rise, the resistance pivots of $25.30 and $25.66 will be of interest.
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
Pfizer has overhead space with shares priced $25.25, or 8.5% below the average consensus analyst price target of $27.61. The stock should discover initial support at its 50-day moving average (MA) of $24.73 and subsequent support at its 200-day MA of $22.97.
Over the past year, Pfizer has traded in a range of $18.77 to $26.09 and is now at $25.25, 35% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has risen 0.2%.